Evidence map›Paper›PMID 32373591›Full record

ArticleFrontiers in chemistry2020

Simple Perylene Diimide Cyclohexane Derivative With Combined CPL and TPA Properties.

Pablo Reine, Ana M Ortuño, Inês F A Mariz, Maria Ribagorda, Juan M Cuerva, Araceli G Campaña, Emerlinda Maçôas, Delia Miguel

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. A Bis-Perylene Diimide Macrocycle Chiroptical Switch.Angewandte Chemie (International ed. in English) · 2025
    Article
  3. Article
  4. Article
  5. Chiral Perylene Bisimide Dyes by Interlocked Arene Substituents in the Bay Area.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pablo ReineDepartamento de Química Orgánica, Facultad de Ciencias, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Universidad de Granada, Granada, Spain.
Ana M OrtuñoDepartamento de Química Orgánica, Facultad de Ciencias, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Universidad de Granada, Granada, Spain.
Inês F A MarizCentro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Maria RibagordaDepartamento de Química Orgánica, Facultad de Ciencias, C.U. Cantoblanco, Universidad Autónoma de Madrid, Madrid, Spain.
Juan M CuervaDepartamento de Química Orgánica, Facultad de Ciencias, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Universidad de Granada, Granada, Spain.
Araceli G CampañaDepartamento de Química Orgánica, Facultad de Ciencias, Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Universidad de Granada, Granada, Spain.
Emerlinda MaçôasCentro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Delia MiguelDepartamento de Fisicoquímica, Facultad de Farmacia, UEQ, Universidad de Granada, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work we describe the linear and non-linear (chiro)optical properties of an enantiopure bis-perylenediimide (PDI) cyclohexane derivative. This compound exhibits upconversion based on a two-photon absorption (TPA) process with a cross-section value of 70 GM together with emission of circularly polarized luminescence (CPL), showing a g

Indexed as

circularly polarized luminiscence (CPL)electronic circular dichroism (ECD)non-linear emissionperylene diimide (PDI)two-photon absorption

Identifiers

PMID32373591
PMCPMC7186504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.